Showing results (741-750 of 1,826) with videos related to

Sort By:
Pageof 183
Signal Transduction and Targeted Therapy|November 18, 2025
Therapeutic targeting of endothelial calcium signaling accelerates the resolution of lung injuryWan Ching Chan, Man Long Kwok, Xinyan Qu, et al.
Signal Transduction and Targeted Therapy|November 27, 2025
Pulsed electromagnetic fields inhibit atherosclerosis by regulating pyroptosis through membrane tension-mediated mechanosensitive channelsHongxin Cheng, Qing Zhang, Wen Zhong, et al.
Signal Transduction and Targeted Therapy|November 27, 2025
Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challengesKhalil Choucair, Hafsa Imtiaz, Md Hafiz Uddin, et al.
Signal Transduction and Targeted Therapy|December 2, 2025
Adipocytes orchestrate obesity-related chronic inflammation through β2-microglobulinJie Li, Yuhao Li, Xiaoyang Zhou, et al.
Signal Transduction and Targeted Therapy|December 23, 2024
The molecular mechanisms of cardiac development and related diseasesYingrui Li, Jianlin Du, Songbai Deng, et al.
Signal Transduction and Targeted Therapy|December 23, 2024
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trialJia Zhong, Kailun Fei, Lin Wu, et al.
Signal Transduction and Targeted Therapy|January 9, 2025
Comparing acute versus AIDS ART initiation on HIV-1 integration sites and clonal expansionJun Wang, Nan Xiao, Zhengnong Zhu, et al.
Signal Transduction and Targeted Therapy|January 8, 2025
Low-input redoxomics facilitates global identification of metabolic regulators of oxidative stress in the gutXina Xiao, Meng Hu, Li Gao, et al.
Signal Transduction and Targeted Therapy|December 26, 2024
Deciphering the molecular basis of lipoprotein recognition and transport by LolCDEWen Qiao, Chongrong Shen, Yujiao Chen, et al.
Signal Transduction and Targeted Therapy|December 17, 2024
Patient-reported outcomes of rezvilutamide versus bicalutamide in combination with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer patients (CHART): a randomized, phase 3 studyHongkai Wang, Shusuan Jiang, Hong Luo, et al.
Pageof 183